Smith Avery, Cooper Barry, Guileyardo Joseph, Mora Adan
Department of Internal Medicine (Smith), Department of Hematology and Oncology (Cooper), Department of Forensic Pathology (Guileyardo), and Division of Pulmonology and Critical Care (Mora), Baylor University Medical Center at Dallas.
Proc (Bayl Univ Med Cent). 2016 Jul;29(3):309-10. doi: 10.1080/08998280.2016.11929447.
Hemoglobin SE disease was first described during the 1950s as a relatively benign microcytosis, but increasing prevalence has revealed a predisposition towards vasoocclusive sickling. Recognition of SE hemoglobinopathies' potential complications is crucial so medical measures can be utilized to avoid multiorgan injury.
血红蛋白SE病在20世纪50年代首次被描述为一种相对良性的小红细胞症,但患病率的上升显示出其易患血管阻塞性镰变的倾向。认识到SE血红蛋白病的潜在并发症至关重要,这样才能采取医疗措施避免多器官损伤。